Central Nervous System Biomarkers Market to Reach US$ 8,628.5 Mn by 2030 with 8.2% CAGR Driven by Advancements in Genomics and Proteomics | Acumen Pharmaceuticals Inc., Alseres Pharmaceuticals Inc., Aposense, Avacta Life Sciences
Reports and Insights (R&I) has recently released a comprehensive report titled, “Central Nervous System Biomarkers...